Pyrrolnitrin

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Pyrrolnitrin
DrugBank Accession Number
DB13603
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 257.07
Monoisotopic: 255.9806328
Chemical Formula
C10H6Cl2N2O2
Synonyms
  • pirrolnitrina
  • Pyrrolnitrin
External IDs
  • NSC-107654

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcenocoumarolThe therapeutic efficacy of Acenocoumarol can be increased when used in combination with Pyrrolnitrin.
DicoumarolThe therapeutic efficacy of Dicoumarol can be increased when used in combination with Pyrrolnitrin.
FluindioneThe therapeutic efficacy of Fluindione can be increased when used in combination with Pyrrolnitrin.
PhenindioneThe therapeutic efficacy of Phenindione can be increased when used in combination with Pyrrolnitrin.
PhenprocoumonThe therapeutic efficacy of Phenprocoumon can be increased when used in combination with Pyrrolnitrin.
Food Interactions
Not Available

Categories

ATC Codes
D01AA07 — Pyrrolnitrin
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as phenylpyrroles. These are polycyclic aromatic compounds containing a benzene ring linked to a pyrrole ring through a CC or CN bond.
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Pyrroles
Sub Class
Substituted pyrroles
Direct Parent
Phenylpyrroles
Alternative Parents
Nitrobenzenes / Nitroaromatic compounds / Chlorobenzenes / Aryl chlorides / Heteroaromatic compounds / Propargyl-type 1,3-dipolar organic compounds / Organic oxoazanium compounds / Azacyclic compounds / Organopnictogen compounds / Organonitrogen compounds
show 3 more
Substituents
3-phenylpyrrole / Allyl-type 1,3-dipolar organic compound / Aromatic heteromonocyclic compound / Aryl chloride / Aryl halide / Azacycle / Benzenoid / C-nitro compound / Chlorobenzene / Halobenzene
show 16 more
Molecular Framework
Aromatic heteromonocyclic compounds
External Descriptors
C-nitro compound, indole alkaloid, monochlorobenzenes, ring assembly, pyrroles (CHEBI:32079) / a chloroaromatic compound (CPD-12776)
Affected organisms
Not Available

Chemical Identifiers

UNII
N0P24B6EDQ
CAS number
1018-71-9
InChI Key
QJBZDBLBQWFTPZ-UHFFFAOYSA-N
InChI
InChI=1S/C10H6Cl2N2O2/c11-8-3-1-2-6(10(8)14(15)16)7-4-13-5-9(7)12/h1-5,13H
IUPAC Name
3-chloro-4-(3-chloro-2-nitrophenyl)-1H-pyrrole
SMILES
[O-][N+](=O)C1=C(Cl)C=CC=C1C1=CNC=C1Cl

References

General References
Not Available
KEGG Compound
C12491
ChemSpider
13314
ChEBI
32079
ChEMBL
CHEMBL97972
ZINC
ZINC000000002012
Wikipedia
Pyrrolnitrin

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0724 mg/mLALOGPS
logP3.86ALOGPS
logP3.85Chemaxon
logS-3.6ALOGPS
pKa (Strongest Acidic)15.06Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count2Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area58.93 Å2Chemaxon
Rotatable Bond Count2Chemaxon
Refractivity61.88 m3·mol-1Chemaxon
Polarizability22.54 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-145.232163
predicted
DarkChem Lite v0.1.0
[M-H]-143.96873
predicted
DeepCCS 1.0 (2019)
[M+H]+146.385163
predicted
DarkChem Lite v0.1.0
[M+H]+146.2511
predicted
DeepCCS 1.0 (2019)
[M+Na]+145.690163
predicted
DarkChem Lite v0.1.0
[M+Na]+152.26167
predicted
DeepCCS 1.0 (2019)

Drug created at June 23, 2017 20:45 / Updated at February 21, 2021 18:54